Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany
Friday, June 06, 2025Telix Pharmaceuticals Limited today announces that its prostate cancer PET imaging agent Illuccix kit for the preparation of gallium gozetotide injection has been granted marketing authorization in Germany
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine
Friday, June 06, 2025NRx Pharmaceuticals Inc a clinicalstage biopharmaceutical company today announced the transmission of its Abbreviated New Drug Application ANDA for electronic filing to the US Food and Drug Administration
Turkish Cargo Named “Cargo Airline of the Year – Global” at the 2025 World Air Cargo Awards
Thursday, June 05, 2025Turkish Cargo the global air cargo brand of Turkish Airlines has been honored with the Cargo Airline of the Year Global award at the World Air Cargo Awards one of the most prestigious accolades in the air cargo industry
Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
Thursday, June 05, 2025Rocheannounced today that the European Commission EC has approved a label extension for Evrysdi risdiplam to include a new roomtemperature stable tablet for people living with spinal muscular atrophy SMA
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
Wednesday, June 04, 2025Orions collaboration partner Bayer announced today that the US Food and Drug Administration FDA has approved the oral androgen receptor inhibitor ARi darolutamide in combination with androgen deprivation therapy ADT
AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
Wednesday, June 04, 2025AbbVie today announced the second annual AbbVie Migraine Career Catalyst Award contest is now accepting entries AbbVie is proud to continue this nationwide initiative supporting people living with migraine by awarding entrants with each that they m...
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
Tuesday, June 03, 2025SCIEX a global leader in life science analytical technologies and operating company of Danaher Corporation NYSE DHR and Evosep Biosystems a global leader in proteomics solutions enter a reseller agreement
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Monday, June 02, 2025Sandoz the global leader in generic and biosimilar medicines has announced that WYOST denosumabbbdz and Jubbonti denosumabbbdz are available to patients in the US starting today
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
Saturday, May 31, 2025Zymeworks Inca clinicalstage biotechnology company developing a diverse pipeline of novel multifunctional biotherapeutics to improve the standard of care for difficulttotreat diseases including cancer inflammation and autoimmune disease today announc...
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA
Friday, May 30, 2025Kexing Biopharmannounced that the National Medical Products Administration NMPA has approved the Investigational New Drug IND application for its independently developed innovative product GB
